The start, scope and design of your project Any good data science project starts with the end goal in mind. The number of possible analyses for a given data set is potentially limitless, and without…
News
Innovation Origins: Digital biomarkers let doctor see how patients are really doing
With specially developed digital biomarkers, you can measure a patient’s health more objectively. This allows doctors to get a better picture of a patient. “In the consultation room, a doctor often only gets a limited…
Digital Health companies in the Nijmegen region
Orikami is featured in the Digital Health Brochure Nijmegen region! Health Valley Netherlands has published a Digital Health Guide together with Radboudumc, Novio Tech Campus, Gemeente Nijmegen and Briskr. The aim: to connect Digital Health players in the Nijmegen…
OpenPlanet
The activities listed below are made possible by the European Union. OpenPlanet is a collaboration between OnePlanet Research Center, iMEC, JoinData, Ivido and Stichting SIDN. By combining the strengths of all partners OnePlanet aims to…
Orikami is the Best Digital Biomarker Company 2021
We are excited to announce that Orikami is mentioned on the Global Health & Pharma website. This year Orikami is a winner in the Healthcare and Pharmaceutical Awards 2021. We are honored for being recognized…
Orikami & Radboudumc, Department of Geriatrics
Highlighted by the need for new, large-scale dementia-prevention and treatment trials, clinicians and researchers urgently need improved tools for remote monitoring of cognitive performance. Commonly used tests are not designed for frequent, remote testing in…
PROMPT – Freezing of Gait / Balance Digital Biomarker
The activities listed below are made possible by the European Union. PROMPT (Personalised-care and Research On Motoric-dysfunctioning for Patient-specific Treatments) project receives a subsidy for the following activity(s): Development of an integrated system for the…
PROHEALTH project
The activities listed below are made possible by the European Union. PROHEALTH project receives a subsidy for the following activity(s): The development and validation of a wearable sensor for measuring cerebral blood flow are based…
PRESS RELEASE: Orikami Takes Over Multiple Screener From Sanofi
Nijmegen, June 28, 2021 Since June 1, 2021, Orikami is the new owner of The Multiple Screener, a cognitive test for MS developed by Sanofi. A new step in which Orikami continues to build on its…
PRESS RELEASE: Orikami brings in new investors
Nijmegen, May 31, 2021 As of May 2021, CbusineZ will join Orikami Group BV, alongside existing investor Healthy.Capital. Both investors enable Orikami to roll out the product MS sherpa to clinical practice and also accelerate…
- 1
- 2